 | Theravance Biopharma, Inc. | |||
| NGM : TBPH || Location: United States | ||||
$9.52-0.17 (-1.75%) |
0.31 M | 9.49 - 9.85 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 7.520 M |
| March 15, 2024 | 8.404 M |
| Feb. 29, 2024 | 8.615 M |
| Feb. 15, 2024 | 8.855 M |
| Jan. 31, 2024 | 8.344 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.15 | -0.17 | -12.14% |
| 09/30/2023 | -0.21 | -0.17 | 20.52% |
| 06/30/2023 | -0.21 | -0.28 | -30.72% |
| 03/31/2023 | -0.25 | -0.35 | -39.28% |
| 12/31/2022 | -0.18 | -0.15 | 14.77% |
TBPH Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 48.560M | Shares Float | 15.865M |
| Short Float | 7.520M | Market Cap | 470.55M |
| Institution ownership | 0.00% | Insider ownership | 14.514% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.08 | Forward EPS | -0.32 |